𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study

✍ Scribed by Leslie Lundt

Book ID
114131585
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
103 KB
Volume
81
Category
Article
ISSN
0165-0327

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Paroxetine in the treatment of depressed
Paroxetine in the treatment of depressed patients with haematological malignancy: an open-label study
✍ Chi-Un Pae; Yoo-Jin Kim; Wang-Youn Won; Hee-Je Kim; Seok Lee; Chang-Uk Lee; Soo- πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 63 KB πŸ‘ 2 views

## Abstract ## Objective The efficacy and tolerability of paroxetine in the treatment of depressive disorders is well known, however, its efficacy and safety for the treatment of depression in patients with cancer has been poorly studied. Therefore this study was aimed at evaluating the efficacy a

The efficacy of reboxetine in the treatm
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study
✍ P. N. Dannon; I. Iancu; L. Grunhaus πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 57 KB πŸ‘ 2 views

## Abstract ## Background and Objective Selective serotonin reuptake inhibitors (SSRIs) are currently the first‐line treatment for panic disorder, although up to 30% of patients either do not respond to SSRIs or withdraw due to adverse events. Reboxetine, a selective norepinephrine reuptake inhibi